https://bioinformatics.umg.eu/onkopus/drugon#anagrelide
Properties
- identifier
- [] pubchem compound:2182
- identifier
- [] kegg drug:d07455
- identifier
- [] pubchem substance:46508863
- identifier
- [] chembl:chembl760
- identifier
- [] pharmgkb:pa164742986
- identifier
- [] chemspider:2097
- synonym
- [] anagrelida
- identifier
- [] bindingdb:50000334
- label
- [] anagrelide
- synonym
- [] anagrelide
- identifier
- [] therapeutic targets database:dap000612
- identifier
- [] rxcui:596724
- identifier
- [] zinc:zinc000003871541
- identifier
- [] pdb:j33
- identifier
- [] chebi:142290
- identifier
- [] drugs product database (dpd):11707
- identifier
- [] wikipedia:anagrelide
- synonym
- [] anagrelidum
Parents
Children
Relations
- has_mesh
- antineoplasticandimmunomodulatingagents
- has_kegg_group
- metabolizingenzymesubstratecyp1a2substrate
- is_inhibitor_for
- pde3a
- has_mesh
- qtcprolongingagents
- has_mesh
- agentsproducingtachycardia
- has_kegg_group
- cardiovascularagentphosphodiesteraseiiiinhibitor
- has_mesh
- narrowtherapeuticindexdrugs
- has_mesh
- phosphodiesterase3inhibitors
- has_mesh
- plateletreducingagents
- has_mesh
- hematologicagents
- has_atc
- l01xxotherantineoplasticagents
- has_atc
- l01antineoplasticagents
- has_mesh
- cardiovascularagents
- has_mesh
- thrombocytosis
- has_mesh
- decreasedplateletproduction
- has_mesh
- antiplateletagents
- has_atc
- l01xotherantineoplasticagents
- has_kegg_group
- metabolizingenzymesubstratecyp1a1substrate
- has_mesh
- antineoplasticagents
- has_mesh
- phosphodiesteraseinhibitors
- has_mesh
- highestriskqtcprolongingagents
- has_atc
- lantineoplasticandimmunomodulatingagents
- has_mesh
- heterocycliccompoundsfusedring
- has_clue_io
- phosphodiesteraseinhibitor